|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 21, 2024 ) The report "Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027", is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Endoscopy is increasingly being used to remove precancerous and cancerous areas in the GI tract. The rising incidence of target diseases such as cancer is expected to accelerate the need for endoscopic procedures, which, in turn, would propel the growth of the endoscopic submucosal dissection market in the coming years. However, the demand for surgeons is steadily increasing, and the supply of future surgeons is not rising at the same rate. Therefore, this shortage will likely reduce the number of yearly ESD procedures.
Download PDF Brochure :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116451960
Based on product, the gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
Based on product, the endoscopic submucosal dissection market is segmented into knives, tissue retractors, graspers/clips, injection agents, gastroscopes and colonoscopes, and other products. The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market in 2021. The large share of the gastroscopes and colonoscopes segment can be attributed to the continuous increase in the prevalence of colorectal cancer and the rising demand for minimally invasive procedures
Based on indication, the stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market
Based on indication, the endoscopic submucosal dissection market is segmented into stomach cancer, colon cancer, and esophageal cancer. The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021. With the rapid growth in the geriatric population, the prevalence of stomach cancer is also expected to increase in the forecast period, thus resulting in a higher demand for endoscopic submucosal dissection procedures.
Based on end user, the hospital segment is expected to dominate the endoscopic submucosal dissection market
Based on end user, the endoscopic submucosal dissection market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. The hospital segment is expected to dominate the endoscopic submucosal dissection market during the forecast period. Increasing investments and incentives received by hospitals from government bodies and private investors for endoscopic surgery and instruments further increase the preference for endoscopic surgeries among physicians.
The Asia Pacific market is expected to grow at a higher CAGR during the forecast period
The APAC market is expected to grow at the highest rate during the forecast period. Factors such as the growing number of hospitals, improving healthcare infrastructure, increasing healthcare expenditure, growing patient population, and surging demand for minimally invasive surgeries are boosting the growth of the endoscopic submucosal dissection market in the Asia Pacific.
Request for Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=116451960
Key players in the endoscopic submucosal dissection market
The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Holdings Corporation (Japan), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical (UK), Medtronic (Ireland), MTW Endoskopie Manufaktur (Germany), HOYA Corporation (Japan), Ovesco Endoscope AG (Germany), Zeon Medical Inc. (Japan), KARL STORZ SE & Co. KG (Germany), ConMed Corporation (US), Micro-tech Endoscopy (China), Cook Group (US), Steris PLC (Ireland), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical (South Korea), DCC Healthcare (Ireland), Kossen Co., Ltd. (South Korea), Innova Medica SPA (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS MedTech Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
